Literature DB >> 28157677

IL-27: a new target for GVHD prevention.

Daniel H Fowler1, Shoba Amarnath2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 28157677      PMCID： PMC5073180          DOI： 10.1182/blood-2016-08-732974

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

1.  Interleukin-27 priming of T cells controls IL-17 production in trans via induction of the ligand PD-L1.

Authors:  Kiyoshi Hirahara; Kamran Ghoreschi; Xiang-Ping Yang; Hayato Takahashi; Arian Laurence; Golnaz Vahedi; Giuseppe Sciumè; Aisling O'Hara Hall; Christopher D Dupont; Loise M Francisco; Qian Chen; Masao Tanaka; Yuka Kanno; Hong-Wei Sun; Arlene H Sharpe; Christopher A Hunter; John J O'Shea
Journal:  Immunity       Date:  2012-06-21       Impact factor: 31.745

2.  Interleukin-27 inhibits the growth of pediatric acute myeloid leukemia in NOD/SCID/Il2rg-/- mice.

Authors:  Alessia Zorzoli; Emma Di Carlo; Claudia Cocco; Emanuela Ognio; Domenico Ribatti; Elisa Ferretti; Carlo Dufour; Franco Locatelli; Daniela Montagna; Irma Airoldi
Journal:  Clin Cancer Res       Date:  2012-03-01       Impact factor: 12.531

3.  Blockade of interleukin-27 signaling reduces GVHD in mice by augmenting Treg reconstitution and stabilizing Foxp3 expression.

Authors:  Ludovic Belle; Kimberle Agle; Vivian Zhou; Cheng Yin-Yuan; Richard Komorowski; Daniel Eastwood; Brent Logan; Jie Sun; Nico Ghilardi; Daniel Cua; Calvin B Williams; Melanie Gaignage; Reece Marillier; Jacques van Snick; William R Drobyski
Journal:  Blood       Date:  2016-08-03       Impact factor: 22.113

Review 4.  The immunobiology of interleukin-27.

Authors:  Hiroki Yoshida; Christopher A Hunter
Journal:  Annu Rev Immunol       Date:  2015       Impact factor: 28.527

5.  IL-27 mediates complete regression of orthotopic primary and metastatic murine neuroblastoma tumors: role for CD8+ T cells.

Authors:  Rosalba Salcedo; Jimmy K Stauffer; Erin Lincoln; Timothy C Back; Julie A Hixon; Cynthia Hahn; Kimberly Shafer-Weaver; Anatoli Malyguine; Robert Kastelein; Jon M Wigginton
Journal:  J Immunol       Date:  2004-12-15       Impact factor: 5.422

6.  Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells.

Authors:  Denise C Fitzgerald; Guang-Xian Zhang; Mohamed El-Behi; Zoë Fonseca-Kelly; Hongmei Li; Shuo Yu; Christiaan J M Saris; Bruno Gran; Bogoljub Ciric; Abdolmohamad Rostami
Journal:  Nat Immunol       Date:  2007-11-11       Impact factor: 25.606

7.  A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells.

Authors:  Amit Awasthi; Yijun Carrier; Jean P S Peron; Estelle Bettelli; Masahito Kamanaka; Richard A Flavell; Vijay K Kuchroo; Mohamed Oukka; Howard L Weiner
Journal:  Nat Immunol       Date:  2007-11-11       Impact factor: 25.606

8.  Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease.

Authors:  Tangsheng Yi; Ying Chen; Lin Wang; Gong Du; Daniel Huang; Dongchang Zhao; Heather Johnston; James Young; Ivan Todorov; Dale T Umetsu; Lieping Chen; Yoichiro Iwakura; Fouad Kandeel; Stephen Forman; Defu Zeng
Journal:  Blood       Date:  2009-07-14       Impact factor: 22.113

9.  The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation.

Authors:  Meghan A Koch; Glady's Tucker-Heard; Nikole R Perdue; Justin R Killebrew; Kevin B Urdahl; Daniel J Campbell
Journal:  Nat Immunol       Date:  2009-05-03       Impact factor: 25.606

10.  Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation.

Authors:  Petra Hoffmann; Joerg Ermann; Matthias Edinger; C Garrison Fathman; Samuel Strober
Journal:  J Exp Med       Date:  2002-08-05       Impact factor: 14.307
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.